KPIs & Operating Metrics(New)
Growth Metrics

AbbVie (ABBV) FCF Margin Growth (5y) (2017 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -1,228.00
Dec 31, 2025 -359.00
Sep 30, 2025 -140.00
Jun 30, 2025 373.00
Mar 31, 2025 -3,232.00
Dec 31, 2024 899.00
Sep 30, 2024 -1,596.00
Jun 30, 2024 -1,442.00
Mar 31, 2024 -592.00
Dec 31, 2023 -756.00
Sep 30, 2023 131.00
Jun 30, 2023 1,105.00
Mar 31, 2023 103.00
Dec 31, 2022 1,668.00
Sep 30, 2022 5,173.00
Jun 30, 2022 3,497.00
Mar 31, 2022 436.00
Dec 31, 2021 1,184.00
Sep 30, 2021 3,297.00
Jun 30, 2021 594.00
Mar 31, 2021 236.00
Dec 31, 2020 461.00
Sep 30, 2020 939.00
Jun 30, 2020 -157,674.00
Mar 31, 2020 1,424.00
Dec 31, 2019 4,916.00
Sep 30, 2019 1,991.00
Jun 30, 2019 -352.00
Mar 31, 2019 2,650.00
Dec 31, 2018 1,796.00
Sep 30, 2018 1,576.00
Jun 30, 2018 -763.00
Mar 31, 2018 645.00
Dec 31, 2017 1,479.00
Sep 30, 2017 -5,189.00
Jun 30, 2017 -3,428.00
Mar 31, 2017 -362.00